The National Agency for Food and Drug Administration and Control (NAFDAC), has cautioned the Nigerian public against the health harm resulting from the circulation of counterfeit malaria drugs bearing the name Aflotin 20/120mg.
The nation’s food and drug regulatory agency warned that the falsified tablets could endanger lives.
In a recent alert tagged Public Alert No. 08/2025, NAFDAC disclosed that the batch in question—Batch No: PA2128L—was originally produced by India-based pharmaceutical company Ajanta Pharma Ltd in December 2018 for a different product, Combisunate 20/120.
NAFDAC stressed the health risk posed by such substandard and falsified medicines, especially in the treatment of Plasmodium falciparum, the most deadly strain of malaria in Nigeria.
NAFDAC urged healthcare professionals and the public to be vigilant.
While calling on collaboration of the public to tackle fake drugs, the Agency said, “Anyone who suspects the circulation or use of fake drugs should report immediately to the nearest NAFDAC office.”
NAFDAC invites such reports via the toll-free number 0800-162-3322 or email at sf.alert@nafdac.gov.ng.
The counterfeit tablets falsely bear a manufacturing date of April 2023 and an expiry date of March 2026, further deepening concerns about their safety and efficacy.
The company confirmed that it has not manufactured any product under the name Aflotin 20/120mg with the stated specifications currently found in Nigeria.
“This batch was originally intended for Combisunate and had a completely different pack configuration,” Ajanta Pharma told NAFDAC, adding that the fake product is being falsely marketed as Aflotin 20/120mg with a pack size of 1 x 18 tablets.
Additionally, the organization said, “The overprinted information and the artwork on the carton do not match Ajanta’s approved design”.
